SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-172996
Filing Date
2009-08-12
Accepted
2009-08-12 16:19:08
Documents
11
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 352069
2 AMENDED AND RESTATED ARTICLES OF INCORPORATION dex31.htm EX-3.1 52771
3 EXCLUSIVE LICENSE AGREEMENT BETWEEN TARGETED GENETICS AND ALKERMES, INC. dex101.htm EX-10.1 28430
4 EIGHTH LEASE AMENDMENT dex102.htm EX-10.2 39893
5 SEVENTH AMENDMENT TO OLIVE WAY BUILDING LEASE dex103.htm EX-10.3 10690
6 LEASE TERMINATION AGREEMENT dex104.htm EX-10.4 33876
7 TARGETED GENETICS CORPORATION STOCK INCENTIVE PLAN dex105.htm EX-10.5 101119
8 CERTIFICATION PURSUANT TO RULES 13A-15(E) AND 15D-15(E) dex311.htm EX-31.1 5848
9 CERTIFICATION PURSUANT TO RULES 13A-15(E) AND 15D-15(E) dex312.htm EX-31.2 5850
10 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3129
11 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3150
  Complete submission text file 0001193125-09-172996.txt   638262
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23930 | Film No.: 091007014
SIC: 2836 Biological Products, (No Diagnostic Substances)